Systematic review of combinations of targeted or immunotherapy in advanced solid tumors
With rapid advances in our understanding of cancer, there is an expanding number of potential novel combination therapies, including novel–novel combinations. Identifying which combinations are appropriate and in which subpopulations are among the most difficult questions in medical research. We con...
Main Authors: | Mustafa Khasraw, Susan M Chang, Amy B Heimberger, Michael Lim, John Simes, Solmaz Sahebjam, Michael Platten, Wolfgang Wick, David M Ashley, Patrick Y Wen, Aaron C Tan, Stephen J Bagley, Howard Colman, Evanthia Galanis, Alireza Mansouri, Simon Khagi, Minesh P Mehta, Vinay K Puduvalli, Scott J Antonia, Don Berry |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-07-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/9/7/e002459.full |
Similar Items
-
Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy
by: Hinda Najem, et al.
Published: (2021-08-01) -
Cancer immunotherapy by targeting IDO1/TDO and their downstream effectors
by: Michael ePlatten, et al.
Published: (2015-01-01) -
K27M-mutant histone-3 as a novel target for glioma immunotherapy
by: Katharina Ochs, et al.
Published: (2017-07-01) -
Using lithium as a neuroprotective agent in patients with cancer
by: Khasraw Mustafa, et al.
Published: (2012-11-01) -
Does age matter? - A MRI study on peritumoral edema in newly diagnosed primary glioblastoma
by: Platten Michael, et al.
Published: (2011-04-01)